Welcome to Ensem Theraputics
Kinetic Ensemble ®
for Precision Medicine
Who We Are
ENSEM is a pioneering drug discovery and development company that leverages its unique Kinetic Ensemble ® platform to develop innovative small molecule precision medicines for oncology, with potential to expand into genetic disorders and other disease areas. ENSEM integrates computational and AI deep learning methodologies with advanced experimental techniques to identify non-obvious binding pockets and accelerate structure-based drug design, with a focus on high-value and difficult-to-drug targets.
Cryptic binding pockets: A small molecule (yellow) induces protein conformational changes (blue) and the opening of a cryptic pocket.
Our Mission is to expand the universe of druggable targets to discover transformative therapies for PATIENTS
Expand The Universe of Druggable targets via AI-powered Kinetic Ensemble ®
ENSEM develops and leverages Artificial Intelligence-powered structural Kinetic Ensemble ® platform to discover cryptic pockets of traditionally undruggable targets, offering new opportunities for therapeutic intervention.
Dedicated to precision medicines
ENSEM leverages big data with advanced modeling and analytics to pioneer breakthrough precision therapies for genetically defined diseases, with Oncology as our initial focus.
We are Entrepreneurs
We blaze new trails with urgency, passion, and resolve. We are bold in scope and optimistic in spirit. We embrace challenges with tenacity and hope.
We do what is Right
We follow the science and act with integrity, care & humility. We are disciplined, rigorous, and accountable for our actions. We focus on patients with transformative medicines.
We are One Ensem
We are a high performing, diverse and inclusive team. We build open and honest relationships. We speak our mind and make it safe for others to do so.